Agency classClass IIOur severity:High FDA (Devices)·Z-2729-2016·Announced 2016-09-14

Hospira Recalls Plum A+3 Infusion Pumps Due to Undersized Diaphragm

Hospira Inc. is recalling 357,778 Plum A+3 Infusion Pumps because an undersized fluid shield diaphragm may cause alarms and interrupt therapy.

The agency’s classification

FDA (Devices): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 3/5 (High).

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall is classified as FDA Class II. The hazard involves the delay or interruption of therapy, which is a risk-of-harm scenario where injury has not yet been reported, fitting the High severity criteria.

Plain-English summary

Hospira Inc. is recalling 357,778 units of the Plum A+3 Infusion Pump, List Number 12618. The recall is due to a defect where the fluid shield diaphragm is undersized. This defect may result in alarms and the delay or interruption of therapy.

The affected devices were distributed nationwide in the United States, including Puerto Rico and the U.S. Virgin Islands, as well as in Costa Rica, Turks and Caicos, and the Dominican Republic. The recall covers specific serial numbers listed in the official FDA record Z-2729-2016.

Hospira Inc. is the recalling firm. The source text does not specify the corrective action consumers or healthcare facilities should take, such as whether to stop using the device or contact the manufacturer for a replacement.

The recalled product

Product: Plum A+3 Infusion Pump. List Number 12618. The Plum A+ Infusion Systems are a multi-purpose family of devices that provides precise delivery of multiple therapies across the general spectrum of clinical care. The Plum A+ family infusion pumps are self-contained, microprocessor…
Manufacturer: Hospira Inc.
Category: Medical Device — Infusion Pump
Hazard: therapy-interruption
device-malfunction
Affected units: 357,778

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

list number 12618. serial numbers: 14040001
14040002
14040003
14040004
14040005
14040006
14040008
14040009
14040010
14040011
14040012
14040014
14040015
14040016
14040017
14040018
14040019
14040020
14040021
14040022

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically:

Part of a larger recall action

This product is one of 9 recalled by Hospira Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 9 products in this recall →

Same manufacturer · Hospira Inc.

See all →

Critical
Hospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
Moderate
Hospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
Low
Hospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
Severe
Hospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
High
Hospira Symbiq Infusion Pump Recalled for White Screen Shutdown
FDA (Devices) · 2016-11-16

Same hazard · therapy interruption